TUESDAY, July 20 (HealthDay News) — The cancer drug Avastin should no longer be used as a treatment for breast cancer, a U.S. Food and Drug Administration advisory panel voted Tuesday, saying the drug wasn’t benefiting patients.
Vote Result
Score: 0.0, Votes: 0
